Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/28298
Title: Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients
Authors: Polonikov, A.
Zvyagina, M.
Krivoshei, I.
Sirotina, S.
Churnosov, M.
Keywords: medicine
medical genetics
genetic polymorphism
coronary artery disease
CAD
lipid-lowering therapy
pharmacology
rosuvastatin
Issue Date: 2015
Citation: Pharmacogenetic study of lipid-lowering therapy with rosuvastatin in coronary artery disease patients / A. Polonikov [et al.] // Annals Academy of Medicine, Singapore. - 2015. - Vol.44, №10, suppl.1.-P. S319. - (Advancing Healthcare Into The Future: Innovate, Improve, Integrate : 6th Singapore Health and Biomedical Congress, Singapore, 2-3 October 2015).
Abstract: Polymorphic genes involved in the regulation of lipid metabolism may be responsible for interindividual differences in efficiency of hypolipidaemic therapy. In the present prospective and randomised study, we investigated the efficacy of rosuvastatin (10 mg/day) in lipid-lowering therapy in 62 patients with coronary artery disease (CAD) possessing different genotypes of lipoprotein lipase (LPL) gene
URI: http://dspace.bsu.edu.ru/handle/123456789/28298
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Sirotina_Pharmacog.pdf18.49 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.